Nifty

:

15778.45

Sensex

:

52653.07

69.05 (0.44%)
209.36 (0.40%)

Login

Nifty
Sensex

:
:

15778.45
52653.07

69.05 (0.44%)
209.36 (0.40%)

Aurobindo Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

56/99

BSE: 524804 | NSE: AUROPHARMA

Watchlist

NSE BSE

908.25

29-Jul-2021

Open
High
Low
Previous Close

920.00
923.10
905.05
915.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1240670
11304.23
1063.90
738.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

53,214.94
9.97
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

55,934.76
0.33%
2.43

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.09
10.86
11.95

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.58
8.82
5.22

PAT CAGR (%)

10 Years
5 Years
3 Years

17.58
7.06
5.55

P:E (Median)

8 Years
5 Years
3 Years

17.03
16.21
15.53

P:BV (Average)

8 Years
5 Years
3 Years

4.26
3.29
2.71

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.93
10.84
10.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 4,114.03 3,638.39 13.07% 3,710.86 3,345.67 10.92% 4,524.34 3,221.66 40.44% 3,419.70 3,078.83 11.07%
Expenses 3,138.00 2,799.21 12.10% 2,737.11 2,694.49 1.58% 3,317.20 2,590.45 28.05% 2,454.87 2,528.42 -2.91%
EBITDA 976.03 839.18 16.31% 973.75 651.18 49.54% 1,207.14 631.21 91.24% 964.83 550.41 75.29%
EBIDTM 23.72% 23.06% 26.24% 19.46% 26.68% 19.59% 28.21% 17.88%
Other Income 267.42 156.50 70.88% 164.97 37.98 334.36% 48.62 33.64 44.53% 125.58 30.14 316.66%
Interest 5.93 20.30 -70.79% 5.84 21.31 -72.60% 6.42 24.86 -74.18% 10.43 31.95 -67.36%
Depreciation 124.07 119.68 3.67% 120.63 118.55 1.75% 120.14 117.93 1.87% 119.79 115.15 4.03%
PBT 1,113.45 855.70 30.12% 1,012.25 549.30 84.28% 1,129.20 522.06 116.30% 960.19 433.45 121.52%
Tax 240.87 138.06 74.47% 271.74 130.23 108.66% 327.66 123.93 164.39% 245.51 102.95 138.47%
PAT 872.58 717.64 21.59% 740.51 419.07 76.70% 801.54 398.13 101.33% 714.68 330.50 116.24%
PATM 21.21% 19.72% 19.96% 12.53% 17.72% 12.36% 20.90% 10.73%
EPS 14.89 12.25 21.55% 12.64 7.15 76.78% 13.68 6.80 101.18% 12.20 5.64 116.31%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 6,001.50 6,158.43 -2.55% 6,364.91 5,895.00 7.97% 6,483.44 5,600.47 15.77% 5,924.78 5,444.60 8.82%
Expenses 4,726.83 4,842.21 -2.38% 4,996.33 4,686.96 6.60% 5,050.63 4,460.25 13.24% 4,667.43 4,298.20 8.59%
EBITDA 1,274.67 1,316.22 -3.16% 1,368.58 1,208.04 13.29% 1,432.81 1,140.22 25.66% 1,257.35 1,146.40 9.68%
EBIDTM 21.24% 21.37% 21.50% 20.49% 22.10% 20.36% 21.22% 21.06%
Other Income 78.10 32.59 139.64% 133.40 30.93 331.30% 53.75 20.62 160.67% 115.59 15.78 632.51%
Interest 18.22 31.83 -42.76% 19.49 37.11 -47.48% 15.71 40.94 -61.63% 21.07 49.89 -57.77%
Depreciation 266.00 232.41 14.45% 276.52 250.13 10.55% 257.34 243.31 5.77% 255.52 240.86 6.09%
PBT 1,069.24 1,096.82 -2.51% 4,019.86 938.81 328.19% 1,213.51 863.83 40.48% 1,096.35 858.73 27.67%
Tax 259.69 214.35 21.15% 1,059.08 232.86 354.81% 387.33 224.37 72.63% 303.67 227.76 33.33%
PAT 809.55 882.47 -8.26% 2,960.78 705.95 319.40% 826.18 639.46 29.20% 792.68 630.97 25.63%
PATM 13.49% 14.33% 46.52% 11.98% 12.74% 11.42% 13.38% 11.59%
EPS 13.68 14.75 -7.25% 50.29 12.04 317.69% 13.76 10.92 26.01% 13.32 10.85 22.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 15,768.93 13,266.48 12,257.89 10,269.90 9,607.05 9,166.18 8,095.10 7,110.71 5,425.10 4,281.45 4,133.12 Net Sales Growth 18.70% 8.23% 19.36% 6.90% 4.81% 13.23% 13.84% 31.07% 26.71% 3.59% Cost Of Goods Sold 7,215.11 5,731.47 5,480.37 4,000.54 4,157.59 3,860.72 3,414.32 3,184.10 2,768.13 2,307.66 2,004.08 Gross Profit 8,553.82 7,535.01 6,777.52 6,269.36 5,449.46 5,305.46 4,680.78 3,926.61 2,656.97 1,973.79 2,129.04 GP Margin 54.24% 56.80% 55.29% 61.05% 56.72% 57.88% 57.82% 55.22% 48.98% 46.10% 51.51% Total Expenditure 11,647.18 10,580.73 9,848.60 7,599.89 7,233.10 6,714.39 5,844.68 5,191.24 4,467.04 3,707.96 3,175.91 Power & Fuel Cost - 520.30 505.96 433.02 405.09 393.06 340.13 335.71 316.34 226.64 184.55 % Of Sales - 3.92% 4.13% 4.22% 4.22% 4.29% 4.20% 4.72% 5.83% 5.29% 4.47% Employee Cost - 1,561.47 1,362.77 1,131.64 927.30 807.05 668.75 514.21 431.42 364.10 303.60 % Of Sales - 11.77% 11.12% 11.02% 9.65% 8.80% 8.26% 7.23% 7.95% 8.50% 7.35% Manufacturing Exp. - 1,740.43 1,606.81 1,299.92 1,099.63 988.18 840.77 680.17 562.43 507.70 464.67 % Of Sales - 13.12% 13.11% 12.66% 11.45% 10.78% 10.39% 9.57% 10.37% 11.86% 11.24% General & Admin Exp. - 404.85 313.98 279.56 279.28 238.72 179.77 137.08 96.76 73.77 64.82 % Of Sales - 3.05% 2.56% 2.72% 2.91% 2.60% 2.22% 1.93% 1.78% 1.72% 1.57% Selling & Distn. Exp. - 387.73 360.62 337.47 251.18 255.70 275.95 213.97 168.34 140.77 116.95 % Of Sales - 2.92% 2.94% 3.29% 2.61% 2.79% 3.41% 3.01% 3.10% 3.29% 2.83% Miscellaneous Exp. - 234.48 218.09 117.74 113.03 170.96 124.99 126.00 123.62 87.32 116.95 % Of Sales - 1.77% 1.78% 1.15% 1.18% 1.87% 1.54% 1.77% 2.28% 2.04% 0.90% EBITDA 4,121.75 2,685.75 2,409.29 2,670.01 2,373.95 2,451.79 2,250.42 1,919.47 958.06 573.49 957.21 EBITDA Margin 26.14% 20.24% 19.66% 26.00% 24.71% 26.75% 27.80% 26.99% 17.66% 13.39% 23.16% Other Income 606.59 403.37 199.22 80.65 135.95 188.36 67.22 74.80 26.51 19.06 57.01 Interest 28.62 240.94 230.86 52.89 45.16 229.31 132.14 288.84 250.06 267.58 55.02 Depreciation 484.63 470.48 413.03 354.83 286.17 263.00 245.15 185.97 171.39 142.94 125.04 PBT 4,215.09 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84 1,940.35 1,519.46 563.12 182.03 834.16 Tax 1,085.78 504.96 434.89 530.17 471.81 521.14 424.00 347.37 67.13 -95.21 211.65 Tax Rate 25.76% 21.24% 22.14% 22.63% 21.66% 24.26% 21.85% 22.86% 11.92% 69.08% 26.28% PAT 3,129.31 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70 1,516.35 1,172.09 495.99 -42.61 593.80 PAT before Minority Interest 3,129.31 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70 1,516.35 1,172.09 495.99 -42.61 593.80 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.84% 14.12% 12.48% 17.65% 17.77% 17.75% 18.73% 16.48% 9.14% -1.00% 14.37% PAT Growth 67.76% 22.42% -15.61% 6.21% 4.92% 7.28% 29.37% 136.31% - - EPS 53.41 31.96 26.11 30.94 29.13 27.76 25.88 20.00 8.47 -0.73 10.13

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 24,774.63 23,098.51 19,563.55 16,463.03 14,909.54 13,794.65 12,120.52 8,099.79 5,855.32 4,627.40 4,381.48 Net Sales Growth 7.26% 18.07% 18.83% 10.42% 8.08% 13.81% 49.64% 38.33% 26.54% 5.61% Cost Of Goods Sold 9,902.48 8,720.74 7,886.32 6,085.55 5,911.00 5,612.30 5,099.89 3,275.54 2,730.00 2,303.99 1,963.83 Gross Profit 14,872.15 14,377.77 11,677.23 10,377.48 8,998.54 8,182.35 7,020.63 4,824.25 3,125.32 2,323.41 2,417.65 GP Margin 60.03% 62.25% 59.69% 63.04% 60.35% 59.32% 57.92% 59.56% 53.38% 50.21% 55.18% Total Expenditure 19,441.22 18,234.20 15,611.61 12,691.28 11,475.26 10,606.53 9,556.90 5,966.14 4,994.37 4,066.10 3,418.22 Power & Fuel Cost - 587.68 556.79 470.95 437.14 419.26 359.60 349.84 324.72 232.36 208.26 % Of Sales - 2.54% 2.85% 2.86% 2.93% 3.04% 2.97% 4.32% 5.55% 5.02% 4.75% Employee Cost - 3,219.18 2,584.87 2,130.84 1,767.76 1,542.62 1,302.26 802.43 663.31 535.69 425.07 % Of Sales - 13.94% 13.21% 12.94% 11.86% 11.18% 10.74% 9.91% 11.33% 11.58% 9.70% Manufacturing Exp. - 2,331.41 2,037.95 1,611.12 1,309.64 1,256.18 1,022.70 772.04 623.04 543.16 511.60 % Of Sales - 10.09% 10.42% 9.79% 8.78% 9.11% 8.44% 9.53% 10.64% 11.74% 11.68% General & Admin Exp. - 1,320.69 1,006.68 1,068.22 997.32 686.38 666.38 283.49 197.83 130.74 120.34 % Of Sales - 5.72% 5.15% 6.49% 6.69% 4.98% 5.50% 3.50% 3.38% 2.83% 2.75% Selling & Distn. Exp. - 1,524.75 1,125.76 1,025.85 848.43 877.14 878.98 359.60 305.98 208.20 141.59 % Of Sales - 6.60% 5.75% 6.23% 5.69% 6.36% 7.25% 4.44% 5.23% 4.50% 3.23% Miscellaneous Exp. - 529.75 413.24 298.75 203.97 212.65 227.09 123.20 149.49 111.96 141.59 % Of Sales - 2.29% 2.11% 1.81% 1.37% 1.54% 1.87% 1.52% 2.55% 2.42% 1.08% EBITDA 5,333.41 4,864.31 3,951.94 3,771.75 3,434.28 3,188.12 2,563.62 2,133.65 860.95 561.30 963.26 EBITDA Margin 21.53% 21.06% 20.20% 22.91% 23.03% 23.11% 21.15% 26.34% 14.70% 12.13% 21.98% Other Income 380.84 191.87 155.32 101.98 115.89 203.80 96.71 21.56 28.54 24.70 71.41 Interest 74.49 305.13 262.60 77.72 66.72 256.70 159.87 310.16 266.64 277.24 64.65 Depreciation 1,055.38 966.71 667.95 557.97 427.63 392.37 332.61 312.53 248.74 200.53 171.50 PBT 7,398.96 3,784.34 3,176.71 3,238.04 3,055.82 2,742.85 2,167.85 1,532.52 374.11 108.23 798.52 Tax 2,009.77 913.52 726.85 818.27 759.65 720.71 596.59 363.45 82.71 -88.81 225.12 Tax Rate 27.16% 24.31% 23.53% 25.27% 24.86% 26.28% 27.52% 23.72% 22.11% 41.70% 28.56% PAT 5,389.19 2,846.14 2,362.03 2,420.03 2,296.64 2,023.64 1,575.77 1,172.85 293.86 -123.50 563.45 PAT before Minority Interest 5,390.21 2,844.69 2,361.80 2,419.77 2,296.17 2,022.14 1,571.26 1,169.07 291.40 -124.14 563.06 Minority Interest 1.02 1.45 0.23 0.26 0.47 1.50 4.51 3.78 2.46 0.64 0.39 PAT Margin 21.75% 12.32% 12.07% 14.70% 15.40% 14.67% 13.00% 14.48% 5.02% -2.67% 12.86% PAT Growth 88.51% 20.50% -2.40% 5.37% 13.49% 28.42% 34.35% 299.12% - - EPS 91.98 48.58 40.31 41.30 39.20 34.54 26.89 20.02 5.02 -2.11 9.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 13,025.56 11,350.62 9,982.58 8,436.18 6,865.85 5,359.54 4,012.39 2,939.11 2,493.17 2,569.61 Share Capital 58.59 58.59 58.59 58.59 58.52 29.20 29.15 29.12 29.11 29.11 Total Reserves 12,966.97 11,291.97 9,923.92 8,377.50 6,806.06 5,330.34 3,983.24 2,909.99 2,464.06 2,540.50 Non-Current Liabilities 149.11 53.64 57.08 139.69 349.16 920.15 1,245.86 1,117.50 841.66 599.86 Secured Loans 0.00 0.00 0.00 118.90 309.19 645.83 978.61 977.13 763.13 401.35 Unsecured Loans 0.00 0.00 0.00 0.00 25.57 41.33 53.70 63.93 70.62 73.59 Long Term Provisions 42.44 22.64 33.60 20.87 21.26 22.65 8.30 8.50 4.12 3.10 Current Liabilities 6,359.90 6,736.46 5,754.18 4,446.97 5,343.69 3,946.19 3,317.28 2,767.96 2,656.38 2,671.70 Trade Payables 1,914.53 1,841.39 1,629.24 1,217.60 1,278.67 1,146.04 1,236.16 901.27 584.85 733.14 Other Current Liabilities 600.19 278.76 396.57 416.60 590.92 504.76 192.39 68.04 405.77 663.33 Short Term Borrowings 3,730.32 4,519.80 3,653.83 2,751.27 3,417.15 2,209.37 1,782.55 1,733.90 1,608.21 1,220.91 Short Term Provisions 114.86 96.51 74.54 61.50 56.95 86.02 106.18 64.75 57.55 54.32 Total Liabilities 19,534.57 18,140.72 15,793.84 13,022.84 12,558.70 10,225.88 8,575.53 6,824.57 5,991.21 5,841.17 Net Block 4,364.69 4,149.70 3,392.97 3,211.62 2,568.13 2,190.01 1,937.94 2,011.91 1,626.74 1,349.89 Gross Block 6,115.18 5,446.15 4,292.18 3,758.18 2,830.78 3,507.54 3,008.82 2,907.49 2,363.26 1,955.17 Accumulated Depreciation 1,750.49 1,296.45 899.21 546.56 262.65 1,317.53 1,070.88 895.58 736.52 605.28 Non Current Assets 8,286.48 7,732.38 6,812.64 6,119.49 4,784.20 3,857.80 3,494.35 3,193.87 2,973.75 2,576.22 Capital Work in Progress 726.62 789.01 1,143.98 906.98 742.14 190.49 155.34 115.65 435.42 467.46 Non Current Investment 2,519.68 2,339.04 1,967.48 1,681.93 1,183.33 993.11 872.59 707.94 610.32 493.04 Long Term Loans & Adv. 628.86 402.93 207.66 233.25 256.70 418.94 463.60 289.10 178.49 196.44 Other Non Current Assets 46.63 51.70 100.55 85.71 33.90 28.55 16.33 18.58 0.12 0.12 Current Assets 11,248.09 10,408.34 8,981.20 6,903.35 7,774.50 6,368.08 5,081.18 3,630.70 3,017.46 3,264.95 Current Investments 0.02 0.02 0.02 0.02 0.02 19.64 0.03 0.04 18.68 0.04 Inventories 4,314.56 3,971.26 3,409.23 2,433.62 2,431.60 2,145.05 1,711.81 1,431.73 1,219.26 1,261.02 Sundry Debtors 5,789.57 5,232.07 4,468.23 3,773.63 4,380.97 3,708.94 2,970.12 1,730.59 1,426.28 1,480.29 Cash & Bank 78.25 75.77 245.90 33.64 330.81 11.13 9.72 114.57 14.01 122.21 Other Current Assets 1,065.69 542.18 428.87 342.73 631.10 483.32 389.50 353.77 339.23 401.39 Short Term Loans & Adv. 605.70 587.04 428.95 319.71 207.62 220.60 174.76 151.41 164.30 310.91 Net Current Assets 4,888.19 3,671.88 3,227.02 2,456.38 2,430.81 2,421.89 1,763.90 862.74 361.08 593.25 Total Assets 19,534.57 18,140.72 15,793.84 13,022.84 12,558.70 10,225.88 8,575.53 6,824.57 5,991.21 5,841.17

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 16,810.38 13,890.78 11,680.42 9,371.91 7,287.30 5,155.91 3,750.15 2,605.76 2,339.65 2,444.83 Share Capital 58.59 58.59 58.59 58.59 58.52 29.20 29.15 29.12 29.11 29.11 Total Reserves 16,751.79 13,832.13 11,621.76 9,313.22 7,227.50 5,126.71 3,721.00 2,576.64 2,310.54 2,415.72 Non-Current Liabilities 565.88 358.13 594.11 102.07 583.85 1,591.60 1,493.91 1,225.26 967.29 645.49 Secured Loans 0.00 48.88 451.20 177.59 380.10 773.54 1,101.31 1,084.11 862.08 449.74 Unsecured Loans 0.00 131.07 0.00 3.81 362.71 587.93 178.05 64.15 102.55 73.61 Long Term Provisions 74.71 46.54 55.86 39.13 23.36 24.35 9.18 9.00 4.24 3.09 Current Liabilities 11,386.75 12,020.57 8,665.89 6,605.60 7,840.22 6,136.40 4,220.04 3,430.83 2,915.05 2,768.49 Trade Payables 2,545.01 2,552.18 2,372.90 2,154.70 2,457.03 2,051.13 1,351.20 963.75 660.14 776.35 Other Current Liabilities 2,874.56 2,510.51 1,967.42 1,286.82 1,577.58 1,364.95 387.68 150.87 580.34 699.09 Short Term Borrowings 5,422.30 6,573.21 4,031.34 2,902.72 3,672.68 2,502.08 2,354.56 2,236.12 1,608.21 1,234.73 Short Term Provisions 544.88 384.67 294.23 261.36 132.93 218.24 126.60 80.09 66.36 58.32 Total Liabilities 28,763.15 26,271.07 20,942.24 16,081.66 15,713.92 12,909.73 9,489.77 7,272.85 6,232.20 5,867.93 Net Block 9,396.47 8,474.85 6,520.68 4,833.78 4,179.69 3,705.64 2,721.67 2,638.87 2,194.65 1,738.60 Gross Block 12,441.26 10,497.62 7,894.78 5,635.49 4,569.83 5,446.13 4,182.96 3,763.47 3,086.25 2,438.00 Accumulated Depreciation 3,044.79 2,022.77 1,374.10 801.71 390.14 1,740.49 1,461.29 1,124.60 891.60 699.40 Non Current Assets 12,350.65 10,938.77 8,764.08 6,875.48 5,419.57 4,610.93 3,858.59 3,136.10 2,968.16 2,546.75 Capital Work in Progress 1,985.94 1,668.46 1,583.04 1,458.08 848.14 370.35 256.67 167.82 515.74 582.86 Non Current Investment 554.69 360.20 311.52 245.85 122.94 0.14 19.76 22.24 19.86 38.49 Long Term Loans & Adv. 376.94 396.64 261.91 256.48 236.56 455.27 789.04 237.82 108.12 110.77 Other Non Current Assets 36.61 38.62 86.93 81.29 32.24 30.25 18.40 18.66 0.12 1.47 Current Assets 16,412.50 15,332.30 12,178.16 9,206.18 10,294.35 8,298.80 5,631.18 4,136.75 3,264.04 3,321.18 Current Investments 0.02 0.02 0.02 0.02 0.02 19.65 0.03 0.04 18.68 0.04 Inventories 7,699.87 7,245.60 5,858.41 4,330.54 4,056.14 3,611.30 2,367.54 1,923.59 1,545.56 1,455.27 Sundry Debtors 4,315.15 3,413.78 3,080.20 2,765.33 4,606.68 3,539.17 2,636.57 1,596.98 1,239.96 1,230.98 Cash & Bank 2,842.15 1,957.18 1,262.25 513.48 800.26 469.11 178.58 208.45 70.86 186.72 Other Current Assets 1,555.31 1,919.82 1,223.32 1,084.72 831.25 659.57 448.46 407.69 388.98 448.17 Short Term Loans & Adv. 1,065.96 795.90 753.96 512.09 366.88 387.90 237.22 207.51 216.67 358.87 Net Current Assets 5,025.75 3,311.73 3,512.27 2,600.58 2,454.13 2,162.40 1,411.14 705.92 348.99 552.69 Total Assets 28,763.15 26,271.07 20,942.24 16,081.66 15,713.92 12,909.73 9,489.77 7,272.85 6,232.20 5,867.93

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 2,161.73 529.89 922.40 2,457.20 1,185.18 590.41 328.03 624.92 504.05 244.57 PBT 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84 1,940.35 1,519.46 563.12 182.04 834.16 Adjustment 396.80 458.99 329.16 303.90 415.22 376.02 415.73 392.48 335.17 143.69 Changes in Working Capital -234.07 -1,411.60 -1,219.73 457.02 -893.68 -1,300.05 -1,268.12 -214.82 15.34 -556.29 Cash after chg. in Working capital 2,540.43 1,012.01 1,452.37 2,939.49 1,669.38 1,016.32 667.07 740.78 532.55 421.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -378.70 -482.12 -529.97 -482.29 -484.20 -425.91 -339.04 -115.86 -28.50 -176.99 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -921.57 -1,297.36 -990.60 -1,542.05 -1,390.11 -623.60 -401.44 -294.96 -533.82 -569.74 Net Fixed Assets -606.64 -799.00 -771.00 -1,092.24 125.11 -533.87 -141.02 -224.46 -376.05 -396.28 Net Investments -180.64 -371.56 -285.55 -498.60 -170.60 -140.13 -164.64 -78.98 -135.92 -122.17 Others -134.29 -126.80 65.95 48.79 -1,344.62 50.40 -95.78 8.48 -21.85 -51.29 Cash from Financing Activity -1,252.39 599.40 439.69 -1,328.99 514.97 34.60 -31.44 -229.40 -78.43 443.12 Net Cash Inflow / Outflow -12.23 -168.07 371.49 -413.84 310.04 1.41 -104.85 100.56 -108.20 117.95 Opening Cash & Equivalents 68.70 239.95 -131.54 283.90 -26.14 9.72 114.57 14.01 122.21 3.98 Closing Cash & Equivalent 59.44 68.70 239.95 -129.94 283.90 11.13 9.72 114.57 14.01 122.21

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 4,381.28 1,650.97 1,954.52 3,278.58 1,419.76 1,236.81 646.28 274.87 326.25 335.11 PBT 3,743.04 3,091.35 3,241.18 3,060.84 2,744.30 2,167.85 1,532.52 374.11 108.23 798.52 Adjustment 1,091.17 813.95 535.02 408.92 487.50 406.28 515.12 441.54 387.22 197.72 Changes in Working Capital 276.87 -1,484.50 -1,123.12 582.52 -1,079.41 -841.73 -1,057.41 -421.56 -128.34 -469.45 Cash after chg. in Working capital 5,111.08 2,420.80 2,653.08 4,052.28 2,152.39 1,732.40 990.23 394.09 367.11 526.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -729.80 -769.83 -698.56 -773.70 -732.63 -495.59 -343.95 -119.22 -40.86 -191.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,567.64 -2,902.59 -1,926.59 -1,787.04 -1,445.21 -1,397.97 -818.74 -246.34 -563.16 -599.07 Net Fixed Assets -606.64 -799.00 -771.00 -1,092.24 125.11 -533.87 -141.02 -224.46 -376.05 -396.28 Net Investments -180.64 -371.56 -285.55 -498.60 -170.60 -140.13 -164.64 -78.98 -135.92 -122.17 Others -780.36 -1,732.03 -870.04 -196.20 -1,399.72 -723.97 -513.08 57.10 -51.19 -80.62 Cash from Financing Activity -1,947.18 1,919.06 864.15 -1,915.26 365.44 93.21 117.64 108.09 118.85 406.98 Net Cash Inflow / Outflow 866.46 667.44 892.08 -423.72 339.99 -67.95 -54.82 136.62 -118.06 143.02 Opening Cash & Equivalents 1,875.58 1,209.94 318.03 743.49 403.81 148.02 202.73 65.64 183.71 44.72 Closing Cash & Equivalent 2,746.82 1,875.58 1,209.94 319.63 743.50 461.10 148.02 202.73 65.64 183.71

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 222.32 193.73 170.38 143.99 117.30 91.77 68.82 50.47 42.82 44.14 ROA 9.94% 9.02% 12.58% 13.34% 14.28% 16.13% 15.22% 7.74% -0.72% 11.38% ROE 15.37% 14.34% 19.68% 22.31% 26.61% 32.36% 33.72% 18.26% -1.68% 26.49% ROCE 16.05% 14.85% 19.02% 19.75% 24.16% 26.60% 28.57% 14.77% 2.55% 19.68% Fixed Asset Turnover 2.30 2.53 2.56 2.97 2.94 2.53 2.46 2.11 2.03 2.43 Receivable days 151.13 143.76 145.99 152.15 158.37 147.84 118.01 103.44 121.14 113.54 Inventory Days 113.61 109.38 103.49 90.78 89.59 85.37 78.92 86.87 103.37 95.17 Payable days 64.05 64.34 67.05 63.93 67.29 74.53 75.91 60.59 66.39 69.93 Cash Conversion Cycle 200.69 188.79 182.43 178.99 180.67 158.68 121.02 129.72 158.13 138.78 Total Debt/Equity 0.29 0.40 0.37 0.36 0.61 0.61 0.73 0.95 1.12 0.90 Interest Cover 10.87 9.51 45.30 49.24 10.37 15.68 6.26 3.25 0.48 15.64

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 286.92 237.08 199.36 159.96 124.50 88.29 64.33 44.74 40.19 41.99 ROA 10.34% 10.00% 13.07% 14.44% 14.13% 14.03% 13.95% 4.32% -2.05% 10.57% ROE 18.53% 18.47% 22.99% 27.57% 32.51% 35.29% 36.79% 11.78% -5.19% 26.35% ROCE 18.80% 17.97% 22.72% 24.92% 27.35% 27.18% 27.18% 11.17% 1.25% 19.29% Fixed Asset Turnover 4.12 4.36 2.44 2.96 2.79 2.55 2.08 1.75 1.71 1.85 Receivable days 29.85 29.56 64.66 89.16 106.53 91.84 93.55 86.28 95.44 89.07 Inventory Days 57.72 59.64 112.70 101.43 100.27 88.91 94.82 105.51 115.91 104.17 Payable days 52.98 58.56 67.77 75.73 81.70 67.49 71.06 57.79 64.70 70.79 Cash Conversion Cycle 34.59 30.63 109.58 114.86 125.10 113.25 117.31 134.00 146.65 122.45 Total Debt/Equity 0.33 0.50 0.41 0.36 0.69 0.86 1.01 1.32 1.32 0.99 Interest Cover 13.32 12.76 42.66 46.80 11.69 14.56 5.94 2.40 0.23 13.19

Top Investors:

life insurance corporation of india

hdfc trustee company limited-hdfc flexi cap fund

qualified institutional buyer

nippon life india trustee ltd-a/c nippon india pharma fund

bnp paribas arbitrage

saudi arabian monetary authority - emerging market

Annual Reports:

News Update:

Aurobindo Pharma reports 7% fall in Q4 consolidated net profit
31st May 2021, 15:00 PM

The company has reported a standalone net profit of Rs 872.58 crore for the quarter ended March 31, 2021
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback